37466-88-9

Basic information

• Product Name: ethyl 2,3-diaMinobenzoate
• Synonyms: ethyl 2,3-diaMinobenzoate;Benzoic acid, 2,3-diaMino-, ethyl ester
• CAS NO: 37466-88-9
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.20378
• Mol File: 37466-88-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 2,3-diaMinobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2,3-diaMinobenzoate(37466-88-9)
• EPA Substance Registry System: ethyl 2,3-diaMinobenzoate(37466-88-9)

Safety Data

• Hazardous Substances Data: 37466-88-9(Hazardous Substances Data)

Usage

General Description

Ethyl 2,3-diaMinobenzoate is a chemical compound commonly known as ethyl 2,3-DAB. It is a white solid that is mainly used as a local anesthetic and an antiarrhythmic agent. It works by blocking sodium channels in nerve fibers, preventing the generation and conduction of electrical signals in the nerve. This property makes it an effective pain-relieving agent, often used in topical creams and ointments. Ethyl 2,3-diaMinobenzoate is also utilized in the synthesis of other pharmaceutical compounds and as a fluorescent probe in biological studies. However, it is important to handle this chemical with care as it can be harmful if ingested or inhaled, and may cause skin and eye irritation.

Upstream product

• 61063-11-4 2-Amino-3-nitrobenzoic acid,ethyl ester 
• 64-17-5 ethanol 
• 54002-28-7 3-acetylamino-2-nitro-benzoic acid 

Downstream Products

• 1314951-83-1 C₇H₁₀N₄O 
• 201412-02-4 4-ethyl formate-2-phenylbenzimidazole 
• 1350454-17-9 ethyl 2-amino-3-[(4-methoxybenzoyl)amino]benzoate 
• 365462-49-3 3-[(4-methoxybenzoyl)amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoic acid hydrochloride 
• 365462-45-9 ethyl 3-[(4-methoxybenzoyl)amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoate hydrochloride 
• 765891-23-4 C₃₀H₃₄N₄O₅ 
• 266993-65-1 2-(4-(1-imidazolyl)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 266993-59-3 2-(4-(2-(N,N-diethylamino)eth-1-yloxy)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 266993-61-7 2-(3-(2-(N,N-diethylamino)eth-1-yloxy)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 832099-52-2 Ethyl 2-amino-3-isopropylamino-benzoate 
• 266993-67-3 2-(3-nitrophenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 266993-63-9 2-(4-nitrophenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 577957-02-9 ethyl 2-ethoxy-3H-benzimidazole-4-carboxylate 
• 560086-13-7 ethyl 2-(2-nitrophenyl)-1H-benzimidazole-4-carboxylate 

Relevant articles and documents

INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTS

The present invention relates to novel substituted biphenyltetrazole compounds useful as intermediates in the preparation of angiotensin II antagonists, to a process for the synthesis of them and to a process for the conversion thereof to said molecules.

IMIDAZO(1,2-a)PYRIDINE DERIVATIVE

A compound reprsented by the following formula (I), its salts or nsolvates thereof capable of specifically or selectively expressig an antifungal activity in a broad spectrum based on the novel mechanism thereof of 1,6-β-glucan synthesis inhibition, and an antifungal agent containing any of them.

Quinoxaline biphenyl angiotensin II inhibitors

Angiotensin II inhibition is exhibited by STR1 wherein: X is --CH2 -- or O; R is hydrogen, alkyl, aryl, cycloalkyl, aralkyl, or cycloalkylalkyl; R1 and R2 are each independently O or absent; R3 is hydrogen, alkyl, alkenyl, alkoxy, cycloalkyl, aryl, aralkyl, cycloalkylalkyl, halo, haloalkyl, or haloalkoxy; R4 is hydrogen, alkyl, alkenyl, alkoxy, aryl, cycloalkyl, aralkyl, cycloalkylalkyl, --R8 --OH, or --R8 CO2 R9 ; and the remaining symbols are as defined in the specification.